Nippon Shinyaku

Company

Nippon Shinyaku develops one asset, in phase 2 (NS-863 in pulmonary arterial hypertension). Mostly small molecule.

1
Asset
Furthest stage
Phase 2
0
Trials
2
Signals

Pipeline

1
  • NS-863

    Phase 2, Small molecule, pulmonary arterial hypertension, Partner

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals3
  • Similar companies6

Intelligence